Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Debiopharm International SA
University of Texas Southwestern Medical Center
National Cancer Institute (NCI)
Northwestern University
Roswell Park Cancer Institute